Parataxis Acquires Korean Biotech Firm, Expands Bitcoin Treasury Platform

In a strategic move to bolster its presence in the South Korean market, Parataxis has acquired a prominent Korean biotech firm. This acquisition serves as a crucial stepping stone in the launch of Parataxis’s innovative Bitcoin-native treasury platform, designed to facilitate institutional investment in BTC. Despite regulatory complexities, this platform, operating through Bridge Bio, aims to bridge the gap and increase accessibility to Bitcoin for institutional investors in South Korea. The acquisition signifies Parataxis’s commitment to expanding Bitcoin adoption within the institutional space, even in challenging regulatory environments. This forward-thinking approach is set to redefine how institutional investors engage with Bitcoin in the South Korean market and beyond.